期刊文献+

临床药师参与阿德福韦酯致低血磷性骨软化症治疗的实践 被引量:3

Practice of Clinical Pharmacists Treated on Adeforvir Ester to Hypohos-phatemic Osteromalecia
下载PDF
导出
摘要 目的:通过临床药师参与阿德福韦酯致低血磷性骨软化症的治疗实践案例,探讨其临床特征及诊治方法,以及临床药师在诊疗过程中所起的作用。方法:总结2例低剂量阿德福韦酯致低血磷性骨软化症成功治疗案例,结合相关指南和文献报道,分析阿德福韦酯致低血磷性骨软化症的临床特征和诊治经过。结果:低剂量阿德福韦酯可导致低血磷性骨软化症,用药期间应定期监测肾功能、血磷、血碱性碱性磷酸酶等。结论:临床药师发挥专业知识技能,参与临床治疗实践,减少误诊,提高临床药物治疗水平。 Objective: Through clinical pharmacists adefovir ester to hypopho-sphatemic osteomalacia treatment practice case,explored the clinical charac-teristics and treatment method,and the role of clinical pharmacists in the process of diagnosis and treatment. Methods: Summarized 2 cases of low dose of adefovir ester to hypophosphatemic osteomalacia treated successfully,combined with the related guidelines and literature reports,analyzed the clinical characteristic and treatment process of adefovir ester to hypophosphatemic osteomalacia. Results: Low dose adefovir ester could lead to hypophosphatemic osteomalacia. The renal function,blood phosphorus and ALP level should be monitored regularly during the medication. Conclusion: Clinical pharmacists gave professional knowledge and skills to participate the clinical practice,it reduced mistake and improved the level of clinical medication.
出处 《药物流行病学杂志》 CAS 2016年第5期317-321,共5页 Chinese Journal of Pharmacoepidemiology
关键词 骨软化症 阿德福韦酯 低磷血症 临床药师 Osteomalacia Adefovir Hypophosphatemia Clinical pharmacists
  • 相关文献

参考文献13

二级参考文献79

  • 1Masami Minemura,Yoshiharu Tokimitsu,Kazuto Tajiri,Yasuhiro Nakayama,Kengo Kawai,Hiroshi Kudo,Katsuharu Hirano,Yoshinari Atarashi,Yutaka Yata,Satoshi Yasumura,Terumi Takahara,Toshiro Sugiyama.Development of osteomalacia in a post-liver transplant patient receiving adefovir dipivoxil[J].World Journal of Hepatology,2010,2(12):442-446. 被引量:13
  • 2谭玲,杨莉萍.果糖二磷酸钠致高磷血症[J].药物不良反应杂志,2004,6(6):405-405. 被引量:4
  • 3陈德海,李惠英,牛跃进.果糖二磷酸钠注射液引起严重放射性疼痛1例[J].中国新药杂志,2005,14(1):32-32. 被引量:2
  • 4毛永辉,王海涛,王松岚,方芳,吴华.二磷酸果糖注射液致急性高磷血症、肾功能衰竭5例[J].药物不良反应杂志,2006,8(2):109-112. 被引量:9
  • 5Tamori A, Enomoto M, Kobayashi S, et al. Add-on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine-refractory hepatitis B virus. J Viral Hepat, 2010, 17 : 123-129.
  • 6Wong T, Girgis CM, Ngu MC, et al. Hypophosphatemic osteomalacia after low-dose adefovir dipivoxil therapy for hepatitis B. J Clin Endocrinol Metab,2010, 95:479-480.
  • 7Girgis CM, Wong T, Ngu MC, et al. Hypophosphataemic osteomalacia in patients on adefovir dipivoxil. J Clin Gastroenterol,2011,45 :468-473.
  • 8Kahn J, Lagakos S, Wulfsohn M, et al. Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial. JAMA, 1999, 282:2305-2312.
  • 9Izzedine H, Hulot JS, Launay-Vacher V, et al. Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two doubleblind, randomized, placebo-controlled studies. Kidney Int, 2004, 66: 1153-1158.
  • 10Bichet DG . Inherited Disorders of the Renal Tubule// Brenner BM. Brenner & rector's the kidney. 8th ed. Philadelphia: Saunders ,2008 : 1390-1393.

共引文献1915

同被引文献29

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部